HMGB3 and non-small cell lung carcinoma: HMGB3 can accelerate the proliferation and colony formation of NSCLC cells, as well as reduce the apoptosis of these cells through the miR-145/HMGB3 signaling pathway, suggesting that HMGB3 can be considered a new marker of poor prognosis for NSCLC patients [208,211].